History

 State-of-the-art Wasco fermentation plant is constructed

Bt production begins at Wasco facility. The facility would create Thuricide, the first Bt product registered for use in the U.S.

With the development of Kleentek technology, sugar cane growers have a clean seed process that produces sugarcane free of systemic diseases that impact production

 The formation of Thermo Trilogy

The acquisition of neem technologies from W.R. Grace, who had previously held the first EPA registration for neem technology 

Thermo Trilogy acquired baculovirus products from Biosys

The acquisition of BT bioinsecticides products from Novartis

Thermo Trilogy leadership helps form Biological Products Industry Alliance, the leading voice for biologicals

The birth of Certis Biologicals after the acquisition of Thermo Trilogy by Mitsui & Co. 

The birth of Certis Biologicals after the acquisition of Thermo Trilogy by Mitsui & Co. 

Under an exclusive distribution agreement, Certis Biologicals partners with German-based Neudorff to expand its portfolio to include DES-X insecticidal soap concentrate, Cueva™ liquid copper fungicide concentrate, Seduce® insecticidal bait and Sluggo® slug and snail bait

Double Nickel and PFR-97 20% WDG granted registration for use in California agriculture

Certis Biologicals acquires Butte, Montana-based LAM International, including their state-of-the-art solid fermentation production facility that complements the Certis Biologicals liquid fermentation production facility in Wasco, California

Certis Biologicals product LifeGard™ WG, the first biological plant activator product in agriculture, is named 2017 Best New Biological Product at the Agrow Awards and received second place for the 2017 Bernard Blum Award for Biocontrol Product of the Year

Through a partnership with OmniLytics, Certis Biologicals introduced the first product utilizing bacteriophages into the agricultural industry, pioneering a new technology for the market to combat resistance issues and solve many pressing agricultural concerns

Construction and start-up completed on the new quadriaction formulation and packaging facility located in Wasco, California. The state-of-the-art system allows Certis Biologicals to produce the highest quality biopesticides

Kocide® 3000-O copper fungicide/bactericide receives approval by the U.S. EPA for use in the organic production of vegetables, small fruits, tree crops and vines

Certis Biologicals introduces Homeplate®, an OMRI Listed®, non-selective, broad-spectrum, fatty acid, burndown herbicide that works as a foliar contact spray to control a wide variety of weeds

Certis Biologicals products are exported to and distributed in 50 countries across the globe. 

Visionary Certis President & CEO Jow-Lih Su, Ph.D., transitions from the leadership position he held for more than 20 years, and Amy O'Shea takes command of Certis Biologicals. 

Certis Biologicals introduces a broader global focus, bringing its portfolio of biological solutions to growers in countries around the world. 

Certis Biologicals continues expanding its biological portfolio and global reach, building on its foundation of microbial technologies and manufacturing expertise. 

Certis Biologicals launches Toltek, a biological seed treatment in Europe. Toltek receives the Gold Bernard Blum Award for Biocontrol Product of the Year, recognizing its contribution to biological crop protection. 

Certis Biologicals launches Convergence biofungicide, expanding its biological crop protection portfolio for row crops. 

Certis Biologicals acquires Howler and Theia fungicides from AgBiome, expanding its biofungicide portfolio and strengthening its solutions for specialty, high-value and large-acreage crops. 

Eda Reinot joins Certis Biologicals as President & CEO, bringing more than 30 years of experience in biologicals and science-led innovation to lead Certis into its next phase of growth. 

Certis Biologicals receives U.S. registration for Nemaclean, a biological nematicide designed to provide growers with a biological option for nematode management. 

Certis Biologicals celebrates 25 years of growth and innovation as a Mitsui & Co. company. The company continues to expand its global portfolio with the launch of Nemaclean in Europe and the renewal of its Bt portfolio in Europe for the next 20 years. Today, Certis Biologicals serves growers in more than 60 countries across all continents, with manufacturing and formulation capabilities spanning the United States, India and Europe.